Wyatt 1990.
Methods | RCT. Method of randomisation and allocation concealment not reported. Blinding at outcome assessment recorded. | |
Participants | 50 patients with minor second‐degree burns who present to an emergency department and/or occupational medicine clinic. Burns which occurred more than 48 hours before presentation for treatment or burns to face, hands, feet or perineum, electrical and chemical burns and those participants with concomitant disease such as diabetes mellitus were excluded. | |
Interventions | Hydrocolloid dressing (DuoDerm, ConvaTec, Squibb) versus SSD (Silvadene, Marion Laboratories) | |
Outcomes | Time to complete wound healing Number of dressing changes Level of pain | |
Notes | Withdrawals:8/50 (16%) Loss to follow‐up: 8/50 (16%) | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Patients "randomly assigned" but no description of method |
Allocation concealment (selection bias) | Unclear risk | Not reported |
Blinding (performance bias and detection bias) All outcomes | High risk | Patients and investigators not blinded as the randomised treatments had different care protocols. One of the outcomes, impression of overall healing, was assessed blindly by one investigator. |
Incomplete outcome data (attrition bias) All outcomes | High risk | 8/50 (16%) patients excluded, 4 because they were lost to follow‐up and 4 because of protocol violations. It is not reported whether the reasons for dropouts were related to group assignment. |
Selective reporting (reporting bias) | Low risk | All prespecified outcomes reported |
Other bias | Unclear risk | Dressing provided by medical equipment company |
C: control ED: emergency department Gp: group I: intervention ITT: intention‐to‐treat NA: not applicable RCT: randomised controlled trial SSD: silver sulphadiazine %TBSA: percentage of total burn surface area